Stock Split History
ETFs Holding VLON »    VLON Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vallon Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of proprietary biopharmaceutical products. Co.'s only clinical-stage product under development is ADAIR, a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of Attention-deficit/hyperactivity disorder, or ADHD, and Narcolepsy. Co. plans to develop other abuse-deterrent products which have potential for abuse in their forms, beginning with the development of ADMIR, an abuse deterrent formulation of Ritalin, for which Co. is conducting formulation development work. According to our Vallon Pharmaceuticals stock split history records, Vallon Pharmaceuticals has had 0 splits.
Vallon Pharmaceuticals stock split history picture
Vallon Pharmaceuticals (VLON) has 0 splits in our Vallon Pharmaceuticals stock split history database.

Looking at the Vallon Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vallon Pharmaceuticals shares, starting with a $10,000 purchase of VLON, presented on a split-history-adjusted basis factoring in the complete Vallon Pharmaceuticals stock split history. Vallon Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/10/2021
End date: 05/17/2021
Start price/share: $7.52
End price/share: $3.69
Dividends collected/share: $0.00
Total return: -50.93%
Annualized Gain: -195.68%
Starting investment: $10,000.00
Ending investment: $4,907.00
Years: 0.26
Date Ratio
LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Vallon Pharmaceuticals

Vallon Pharmaceuticals Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.